Effect of alpha-lipoic acid in ß-thalassemia major patients.

Phase 3

• Conditions: Beta thalassaemia.; Beta thalassaemia; D56.1

• Registration Number: IRCT20131013014994N6
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Age: 15 - 35 years old

Exclusion Criteria

History of hepatitis B and C
Heart failure, renal failure
Cancer
Allergies
Digestive problems disrupting drug intake
Pregnancy
Smoking
Consumption of other than desphonac
Adherence to a particular diet

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Homocysteine (HCY). Timepoint: The beginning of the study and the end of week 8, 11 and 19. Method of measurement: Eliza.;Lipoprotein-associated phospholipase A2 (Lp-PLA2). Timepoint: The beginning of the study and the end of week 8, 11 and 19. Method of measurement: Eliza.;Trimethylamine N-oxide (TMAO). Timepoint: The beginning of the study and the end of week 8, 11 and 19. Method of measurement: Eliza.;Osteoprotegerin (OPG). Timepoint: The beginning of the study and the end of week 8, 11 and 19. Method of measurement: Eliza.